IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9333249 B1

PDFFull Text
Date of Patent:
May. 10, 2016

Filed:

Aug. 15, 2008

Recombinant baculovirus vaccine

Applicants:

Shigeto Yoshida, Tochigi, JP;

Masanori Kawasaki, Osaka, JP;

Makoto Matsumoto, Osaka, JP;

Yoshio Ohba, Osaka, JP;

Masahiro Saito, Osaka, JP;

Yoshihiro Goto, Osaka, JP;

Katsuya Inagaki, Osaka, JP;

Masami Mizukoshi, Osaka, JP;

Norimitsu Hariguchi, Osaka, JP;

Kuniko Hirota, Osaka, JP;

Inventors:

Shigeto Yoshida, Tochigi, JP;

Masanori Kawasaki, Osaka, JP;

Makoto Matsumoto, Osaka, JP;

Yoshio Ohba, Osaka, JP;

Masahiro Saito, Osaka, JP;

Yoshihiro Goto, Osaka, JP;

Katsuya Inagaki, Osaka, JP;

Masami Mizukoshi, Osaka, JP;

Norimitsu Hariguchi, Osaka, JP;

Kuniko Hirota, Osaka, JP;

Assignees:

EDUCATIONAL FOUNDATION JICHI MEDICAL UNIVERSITY, Tochigi, JP;

OTSUKA PHARMACEUTICAL CO., LTD., Tokyo, JP;

Attorney:

Sughrue Mion, PLLC

Primary Examiner:

Shanon A Foley

Assistant Examiner:

Myron Hill

Int. Cl.
CPC ...
A61K 39/145 (2006.01); C12N 15/00 (2006.01); A61K 35/76 (2015.01); A61K 9/127 (2006.01); A61K 39/015 (2006.01); A61K 39/04 (2006.01); C07K 14/005 (2006.01); A61K 39/12 (2006.01); A61K 9/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/015 (2013.01); A61K 39/04 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); C07K 14/005 (2013.01); A61K 9/007 (2013.01); A61K 9/0043 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/543 (2013.01); C07K 2319/00 (2013.01); C07K 2319/02 (2013.01); C12N 2710/14143 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/16134 (2013.01);
Abstract

The present invention provides a novel transfer vector and a recombinant baculovirus; methods for the production thereof; pharmaceuticals containing the recombinant baculovirus as an active ingredient, which are useful as preventive or therapeutic drugs for infectious diseases such as malaria and influenza; and methods for preventing and treating infectious diseases such as malaria and influenza. More specifically, the invention provides a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter; a recombinant baculovirus; methods for the production thereof; pharmaceuticals containing the recombinant baculovirus as an active ingredient; and methods for preventing and treating infectious diseases such as malaria and influenza comprising administrating the recombinant baculovirus to patients.

Find Patent Forward Citations

Loading…